Which has the lower trailing P/E, ADMA or LQDA?

ADMA has the lower trailing P/E: ADMA trades at 14.56 and LQDA at 19.18. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ADMA or LQDA?

Over the past five years, LQDA grew revenue faster — ADMA at a 54.55% CAGR versus LQDA at 128.77%.

Is ADMA or LQDA more profitable?

ADMA runs the higher net margin — ADMA at 32.98% versus LQDA at 30.74%.

How have ADMA and LQDA total returns compared?

Over the past 5 years, ADMA delivered 54.74% and LQDA delivered 59.01% annualized total return. Past performance doesn't predict future results.

ADMA Biologics, Inc. (ADMA) vs Liquidia Corporation (LQDA)

A side-by-side comparison of ADMA Biologics, Inc. and Liquidia Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADMA

ADMA Biologics, Inc.

$2.36B

$10.19HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT

LQDA

Liquidia Corporation

$2.34B

$26.26HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT

Total return — ADMA vs LQDA

growth of $100 · dividends reinvested · last 8y

ADMA +104.7% (+9.4%/yr)LQDA +149.0% (+12.1%/yr)LQDA compounded faster over this window

ADMA LQDA

ADMA vs LQDA: by the numbers

•ADMA is the larger company ($2.36B vs $2.34B market cap).
•ADMA trades at the lower trailing earnings multiple (14.56 vs 19.18 P/E), one valuation lens rather than an overall verdict.
•ADMA converts more revenue to profit (32.98% vs 30.74% net margin).
•LQDA grew revenue faster over the past five years (128.77% vs 54.55% CAGR).

Metrics side by side

Valuation

Metric	ADMA	LQDA
P/E ratio	14.56	19.18
Forward P/E	12.79	10.57
P/S ratio	4.61	5.18
P/B ratio	5.78	11.97
EV / EBITDA	10.75	12.81
FCF yield	4.93%	2.59%

Profitability

Metric	ADMA	LQDA
Gross margin	64.71%	92.48%
Operating margin	42.26%	-32.45%
Net margin	32.98%	30.74%
ROE	41.39%	71.04%
ROIC	27.60%	46.99%

Growth (annualized)

Metric	ADMA	LQDA
Revenue CAGR (5Y)	54.55%	128.77%
Total return CAGR (5Y)	54.74%	59.01%

Frequently asked

Which has the lower trailing P/E, ADMA or LQDA?: ADMA has the lower trailing P/E: ADMA trades at 14.56 and LQDA at 19.18. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ADMA or LQDA?: Over the past five years, LQDA grew revenue faster — ADMA at a 54.55% CAGR versus LQDA at 128.77%.
Is ADMA or LQDA more profitable?: ADMA runs the higher net margin — ADMA at 32.98% versus LQDA at 30.74%.
How have ADMA and LQDA total returns compared?: Over the past 5 years, ADMA delivered 54.74% and LQDA delivered 59.01% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ADMA analysis Full LQDA analysis Interactive comparison tool

Dig into the metrics

ADMA Biologics P/E ratio Liquidia P/E ratio ADMA Biologics ROE Liquidia ROE ADMA Biologics operating margin Liquidia operating margin ADMA Biologics revenue growth Liquidia revenue growth ADMA Biologics free cash flow Liquidia free cash flow

ADMA Biologics & Liquidia appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.